Cargando…
Destruction of Full-Length Androgen Receptor by Wild-Type SPOP, but Not Prostate-Cancer-Associated Mutants
The SPOP E3 ubiquitin ligase gene is frequently mutated in human prostate cancers. Here, we demonstrate that SPOP recognizes a Ser/Thr-rich degron in the hinge domain of androgen receptor (AR)and induces degradation of full-length AR and inhibition of AR-mediated gene transcription and prostate canc...
Autores principales: | An, Jian, Wang, Chenji, Deng, Yibin, Yu, Long, Huang, Haojie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361392/ https://www.ncbi.nlm.nih.gov/pubmed/24508459 http://dx.doi.org/10.1016/j.celrep.2014.01.013 |
Ejemplares similares
-
The novel BET‐CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild‐type prostate cancer
por: Yan, Yuqian, et al.
Publicado: (2019) -
Dysregulation of INF2-mediated mitochondrial fission in SPOP-mutated prostate cancer
por: Jin, Xiaofeng, et al.
Publicado: (2017) -
Prostate cancer-associated SPOP mutations lead to genomic instability through disruption of the SPOP–HIPK2 axis
por: Jin, Xiaofeng, et al.
Publicado: (2021) -
Dual functions of SPOP and ERG dictate androgen therapy responses in prostate cancer
por: Bernasocchi, Tiziano, et al.
Publicado: (2021) -
Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer
por: Liu, Deli, et al.
Publicado: (2018)